Bibliografie
1. Di Dalmazi G, Pasquali R, Beuschlein F, Reincke M (2015). Subclinical hypercortisolism: a state, a syndrome, or a disease? Eur J Endocrinol, 173(4), M61-71. doi: 10.1530/EJE-15-0272.
2. Di Dalmazi G, Vicennati V, Garelli S, Casadio E, Rinaldi E, Giampalma E, Mosconi C, Golfieri R, Paccapelo A, Pagotto U, Pasquali R (2014). Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing’s syndrome: a 15-year retrospective study. Lancet Diabetes Endocrinol, 2(5), 396-405.
3. Zografos GN, Perysinakis I, Vassilatou E (2014). Subclinical Cushing’s syndrome: current concepts and trends. Hormones (Athens), 13(3), 323-37. doi: 10.14310/horm.2002.1506.
4. Poiană C, Chiriţă C, Carsote M, Hortopan D, Ioachim D, Corneci CM, Stănescu B (2013). Adrenal and pituitary incidentalomas in a case of Cushing’s syndrome. Chirurgia (Bucur), 108(6), 886-91.
5. Carsote M, Chirita C, Dumitrascu A, Hortopan D, Fica S, Poiana C (2009). Pituitary incidentalomas - how often is too often? J Med Life, 2(1), 92-7.
6. Nieman LK. (2015) Cushing’s syndrome: update on signs, symptoms and biochemical screening. Eur J Endocrinol, 173(4), M33-8. doi: 10.1530/EJE-15-0464.
7. Ferraù F, Korbonits M. (2015) Metabolic comorbidities in Cushing’s syndrome. Eur J Endocrinol,173(4), M133-57. doi: 10.1530/EJE-15-0354.
8. Santos A, Resmini E, Gómez-Ansón B, Crespo I, Granell E, Valassi E, Pires P, Vives-Gilabert Y, Martínez-Momblán MA, de Juan M, Mataró M, Webb SM. (2015) Cardiovascular risk and white matter lesions after endocrine control of Cushing’s syndrome. Eur J Endocrinol, 173(6), 765-75. doi: 10.1530/EJE-15-0600.
9. Petramala L, Lorenzo D, Iannucci G, Concistré A, Zinnamosca L, Marinelli C, De Vincentis G, Ciardi A, De Toma G, Letizia C (2015). Subclinical Atherosclerosis in Patients with Cushing Syndrome: Evaluation with Carotid Intima-Media Thickness and Ankle-Brachial Index. Endocrinol Metab (Seoul), 30(4), 488-93. doi: 10.3803/EnM.2015.30.4.488.
10. Goddard GM, Ravikumar A, Levine AC (2015). Adrenal mild hypercortisolism. Endocrinol Metab Clin North Am, 44(2), 371-9. doi: 10.1016/j.ecl.2015.02.009.
11. Kaltsas G, Chrisoulidou A, Piaditis G, Kassi E, Chrousos G (2012). Current status and controversies in adrenal incidentalomas. Trends Endocrinol Metab, 23(12), 602-9. doi: 10.1016/j.tem.2012.09.001.
12. Glenn JA, Kiernan CM, Yen TW, Solorzano CC, Carr AA, Evans DB, Wang TS (2016). Management of suspected adrenal metastases at 2 academic medical centers. Am J Surg, 211(4), 664-70. doi: 10.1016/j.amjsurg.2015.11.019.
13. Ginzburg S, Reddy M, Veloski C, Sigurdson E, Ridge JA, Azrilevich M, Kutikov A (2015). Papillary Thyroid Carcinoma Metastases Presenting as Ipsilateral Adrenal Mass and Renal Cyst. Urol Case Rep, 3(6), 221-2. doi: 10.1016/j.eucr.2015.08.007.
14. Gryn A, Peyronnet B, Manunta A, Beauval JB, Bounasr E, Nouhaud FX, Rioux-Leclercq N, Caron P, Thoulouzan M, Verhoest G, Soulie M, Bensalah K, Huyghe E (2015). Patient selection for laparoscopic excision of adrenal metastases: A multicenter cohort study. Int J Surg, 24(Pt A):75-80. doi: 10.1016/j.ijsu.2015.10.038.
15. Kebebew E, Siperstein AE, Clark OH, Duh QY (2002). Results of laparoscopic adrenalectomy for suspected and unsuspected malignant adrenal neoplasms. Arch Surg, 137(8), 948-51; discussion 952-3.
16. Moinzadeh A, Gill IS (2005). Laparoscopic radical adrenalectomy for malignancy in 31 patients. J Urol, 173(2), 519-25.
17. Lheureux S, Oza AM (2016). Endometrial cancer-targeted therapies - myth or reality? Review of current targeted treatments. Eur J Cancer, 59:99-108. doi: 10.1016/j.ejca.2016.02.016.
18. Laskey RA, McCarroll ML, von Gruenigen VE (2016). Obesity-related endometrial cancer: an update on survivorship approaches to reducing cardiovascular death. BJOG,123(2):293-8. doi: 10.1111/1471-0528.13684.
19. Cetinkaya K, Atalay F, Bacinoglu A, Dervisoglu H (2016). To what extent is risk grouping method successful in deciding surgical staging in endometrial cancer? Tumori, 30:0. doi: 10.5301/tj.5000497.
20. Kamal A, Tempest N, Parkes C, Alnafakh R, Makrydima S, Adishesh M, Hapangama DK (2016). Hormones and endometrial carcinogenesis. Horm Mol Biol Clin Investig, 25(2):129-48. doi: 10.1515/hmbci-2016-0005.
21. Pisano G, Calò PG, Erdas E, Pigliaru F, Piras S, Sanna S, Manca A, Dazzi C, Nicolosi A (2015). Adrenal incidentalomas and subclinical Cushing syndrome: indications to surgery and results in a series of 26 laparoscopic adrenalectomies. Ann Ital Chir, 86:406-12.
22. Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V, Lombardi G (2000). Subclinical Cushing’s syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab, 5(4):1440-8.
23. Albu SE, Carsote M, Capatina C, Dumitrascu A, Ghemigian A (2015). Adrenal surgical approach in a woman with synchronous bilateral adrenal tumours. Journal of Surgical Sciences, 2(3):132-135.
24. M. Carsote, A. Ghemigian, A. Valea, A. Dumitrascu, C. Chirita, C. Poiana (2015). Sublinical Cushing’s syndrome with bilateral adrenal tumours in a patient with gallbladder multiple stone: therapeutical options. Ars Medica Tomitana, 3(21):124-127.
25. Carsote M, Valea A, Dumitraşcu A, Terzea D, Păun S, Poiană C (2015). The unilateral adrenal tumor in a patient with history of uterine cervix cancer: the radiological and endocrine profile related management. International Journal of Diagnosis Imaging, 2(2):90-95.
26. Bartosch C, Afonso M, Pires-Luís AS, Galaghar A, Guimarães M, Antunes L, Lopes JM. (2016) Distant Metastases in Uterine Leiomyosarcomas: The Wide Variety of Body Sites and Time Intervals to Metastatic Relapse. Int J Gynecol Pathol. 2016 Mar 24. [Epub ahead of print]
27. Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA. (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 8:136. doi: 10.1007/s11657-013-0136-1.
28. Poiana C, Carsote M, Capatina C, Radoi V, Ghemigian A. (2015) Vitamin D in menopause: a cross-sectional study on 471 women. Romanian Journal of Rheumatology, XXIV(1): 40-44.
29. Albu SE, Geleriu A, Carsote M, A Mihai, C. Vasiliu, C. Poiana. (2015) The vitamin D status in menopausal women. Archives of Balkan Medical Union, 50(2): 275-277.
30. Capatina C, Carsote M, Caragheorgheopol A, Poiana C, Berteanu M. (2014) Vitamin D deficiency in postmenopausal women – biological correlates. Maedica: a Journal of Clinical Medicine, 9(4): 316-322.